Yoichi Nishii

704 total citations
43 papers, 463 citations indexed

About

Yoichi Nishii is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Yoichi Nishii has authored 43 papers receiving a total of 463 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Pulmonary and Respiratory Medicine, 14 papers in Oncology and 6 papers in Molecular Biology. Recurrent topics in Yoichi Nishii's work include Lung Cancer Treatments and Mutations (16 papers), Lung Cancer Diagnosis and Treatment (10 papers) and Tracheal and airway disorders (6 papers). Yoichi Nishii is often cited by papers focused on Lung Cancer Treatments and Mutations (16 papers), Lung Cancer Diagnosis and Treatment (10 papers) and Tracheal and airway disorders (6 papers). Yoichi Nishii collaborates with scholars based in Japan, Germany and United States. Yoichi Nishii's co-authors include Osamu Taguchi, Esteban C. Gabazza, Hajime Fujimoto, Osamu Hataji, Corina N. D’Alessandro‐Gabazza, Kentaro Ito, Yukihiko Adachi, Tadashi Sakaguchi, Koji Suzuki and Tatsuya Hayashi and has published in prestigious journals such as SHILAP Revista de lepidopterología, American Journal of Respiratory and Critical Care Medicine and Scientific Reports.

In The Last Decade

Yoichi Nishii

37 papers receiving 454 citations

Peers

Yoichi Nishii
Yoichi Nishii
Citations per year, relative to Yoichi Nishii Yoichi Nishii (= 1×) peers Hideki Makino

Countries citing papers authored by Yoichi Nishii

Since Specialization
Citations

This map shows the geographic impact of Yoichi Nishii's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoichi Nishii with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoichi Nishii more than expected).

Fields of papers citing papers by Yoichi Nishii

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoichi Nishii. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoichi Nishii. The network helps show where Yoichi Nishii may publish in the future.

Co-authorship network of co-authors of Yoichi Nishii

This figure shows the co-authorship network connecting the top 25 collaborators of Yoichi Nishii. A scholar is included among the top collaborators of Yoichi Nishii based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoichi Nishii. Yoichi Nishii is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nishii, Yoichi, Tadashi Sakaguchi, Yūta Suzuki, et al.. (2025). Suitability of Specimens from Pleural Dissemination of Non-Small Cell Lung Cancer for Genetic Testing Using Forceps and Cryobiopsy. Respiration. 104(11). 814–824.
2.
Sakaguchi, Tadashi, et al.. (2023). A case of tracheal stenosis due to anaplastic thyroid carcinoma treated using the stent‐in‐stent method. Thoracic Cancer. 15(4). 350–352. 1 indexed citations
3.
Nishii, Yoichi, Tadashi Sakaguchi, Yuki Nakamura, et al.. (2023). Close-to-lesion transbronchial biopsy: a novel technique to improve suitability of specimens for genetic testing in patients with peripheral pulmonary lesions. Scientific Reports. 13(1). 14724–14724. 3 indexed citations
4.
Ito, Atsushi, Yūta Suzuki, Tadashi Sakaguchi, et al.. (2023). Clinicopathological and Molecular Characteristics Promoting PD-L1 Expression in Early-stage Lung Adenocarcinoma and Squamous Cell Carcinoma. Anticancer Research. 43(11). 5197–5204. 1 indexed citations
5.
Sakaguchi, Tadashi, Yūta Suzuki, Kentaro Ito, et al.. (2023). Clinical importance of the range of detectable variants between the Oncomine Dx target test and a conventional single-gene test for EGFR mutation. Scientific Reports. 13(1). 13759–13759. 5 indexed citations
6.
Oki, Masahide, Hideo Saka, Daisuke Himeji, et al.. (2022). Value of adding ultrathin bronchoscopy to thin bronchoscopy for peripheral pulmonary lesions: A multicentre prospective study. Respirology. 28(2). 152–158. 9 indexed citations
7.
Kogure, Yoshihito, Akiko Kada, Hiroya Hashimoto, et al.. (2022). 1160P Survival impact of second-line immune checkpoint inhibitors in the elderly patients with advanced squamous non-small cell lung cancer: Post-hoc analysis from a CAPITAL study. Annals of Oncology. 33. S1079–S1079. 1 indexed citations
8.
Sakaguchi, Tadashi, Yasumasa Kokubo, Kazuki Furuhashi, et al.. (2021). An Extensive-stage Small-cell Lung Cancer Case With Preexisting Lambert-Eaton Myasthenic Syndrome Successfully Treated With an Immune Checkpoint Inhibitor. Clinical Lung Cancer. 23(3). e273–e275. 8 indexed citations
9.
Nishii, Yoichi, Yuki Nakamura, Kentaro Fujiwara, et al.. (2020). Use of Ultrathin Bronchoscope on a Need Basis Improves Diagnostic Yield of Difficult-to-Approach Pulmonary Lesions. Frontiers in Medicine. 7. 588048–588048. 9 indexed citations
10.
Sakaguchi, Tadashi, Kentaro Ito, Kazuki Furuhashi, et al.. (2019). Patients with unresectable stage III non-small cell lung cancer eligible to receive consolidation therapy with durvalumab in clinical practice based on PACIFIC study criteria. Respiratory Investigation. 57(5). 466–471. 36 indexed citations
11.
Nishii, Yoichi, Taro Yasuma, Kentaro Ito, et al.. (2019). Factors leading to failure to diagnose pulmonary malignant tumors using endobronchial ultrasound with guide sheath within the target lesion. Respiratory Research. 20(1). 207–207. 14 indexed citations
12.
Nakamura, Yuki, Tetsu Kobayashi, Yoichi Nishii, et al.. (2018). Comparable immunoreactivity rates of PD‐L1 in archival and recent specimens from non‐small cell lung cancer. Thoracic Cancer. 9(11). 1476–1482. 7 indexed citations
13.
Imashuku, Shinsaku, et al.. (2018). Topical Imiquimod for the Treatment of Relapsed Cutaneous Langerhans Cell Histiocytosis after Chemotherapy in an Elderly Patient. Case Reports in Dermatological Medicine. 2018. 1–5. 2 indexed citations
14.
Nishii, Yoichi, Kentaro Ito, Fumiaki Watanabe, et al.. (2017). Efficacy of osimertinib in a patient with non‑small cell lung cancer harboring epithelial growth factor receptor exon 19 deletion/T790M mutation, with poor performance status. Molecular and Clinical Oncology. 6 indexed citations
15.
Fujimoto, Hajime, Esteban C. Gabazza, Osamu Taguchi, et al.. (2006). Thrombin-Activatable Fibrinolysis Inhibitor Deficiency Attenuates Bleomycin-Induced Lung Fibrosis. American Journal Of Pathology. 168(4). 1086–1096. 33 indexed citations
16.
Nishii, Yoichi, Esteban C. Gabazza, Hajime Fujimoto, et al.. (2006). Protective role of protein C inhibitor in monocrotaline‐induced pulmonary hypertension. Journal of Thrombosis and Haemostasis. 4(11). 2331–2339. 17 indexed citations
17.
Gabazza, Esteban C., Hajime Fujimoto, Yoichi Nishii, et al.. (2006). Deficiency of tenascin C attenuates allergen‐induced bronchial asthma in the mouse. European Journal of Immunology. 36(12). 3334–3345. 55 indexed citations
18.
Hataji, Osamu, Osamu Taguchi, Esteban C. Gabazza, et al.. (2004). Increased circulating levels of thrombin‐activatable fibrinolysis inhibitor in lung cancer patients. American Journal of Hematology. 76(3). 214–219. 38 indexed citations
19.
Gabazza, Esteban C., Michael Kasper, Michael P. Keane, et al.. (2004). Decreased expression of aquaporin‐5 in bleomycin‐induced lung fibrosis in the mouse. Pathology International. 54(10). 774–780. 44 indexed citations
20.
Nishii, Yoichi, Masaki Morishima, Yoshiyuki Kakehi, et al.. (2003). Effect of cisplatin treatment on speckled distribution of a serine/arginine-rich nuclear protein CROP/Luc7A. Biochemical and Biophysical Research Communications. 301(2). 324–329. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026